Cargando…
Radiomic Signatures Associated with CD8(+) Tumour-Infiltrating Lymphocytes: A Systematic Review and Quality Assessment Study
SIMPLE SUMMARY: Immune checkpoint inhibitors can be effective drugs to treat cancer. However, only a minority of patients derive benefits. An important determinant of treatment success is the abundance of CD8-expressing tumour-infiltrating lymphocytes (CD8(+) TILs) in target tumours. The measurement...
Autores principales: | Ramlee, Syafiq, Hulse, David, Bernatowicz, Kinga, Pérez-López, Raquel, Sala, Evis, Aloj, Luigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367613/ https://www.ncbi.nlm.nih.gov/pubmed/35954318 http://dx.doi.org/10.3390/cancers14153656 |
Ejemplares similares
-
Prognostic Significance of CD4+ and CD8+ Tumor-Infiltrating Lymphocytes in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis
por: Borsetto, Daniele, et al.
Publicado: (2021) -
Tumour-infiltrating CD8(+) lymphocytes and colorectal cancer recurrence by tumour and nodal stage
por: Glaire, Mark A., et al.
Publicado: (2019) -
Tumour-infiltrating CD4(+) and CD8(+) lymphocytes as predictors of clinical outcome in glioma
por: Han, S, et al.
Publicado: (2014) -
The difference and relationship of CD4+ and CD8+ tumour infiltrating lymphocytes in lung adenocarcinoma
por: Zhang, Chaoting, et al.
Publicado: (2019) -
Correction: Tumour-infiltrating CD8(+) lymphocytes and colorectal cancer recurrence by tumour and nodal stage
por: Glaire, Mark A., et al.
Publicado: (2019)